22 Hrs
Source:
معلومات مباشر
Source: معلومات مباشر
22 Hrsمعلومات مباشر
Source: معلومات مباشر
22 HrsReady to play
Ready to play
Moderna raised its forecast for annual revenue growth in 2026 to 15%–25%, driven by strong international demand for its COVID-19 vaccine and payments from strategic partnerships. The company posted a net profit of $162 million in the third quarter, compared with a $200 million loss a year earlier, and revenue of $1.3 billion. Its shares rose more than 10%.
Notice: This Is an AI-Generated Summary
Comments (0)